Department of Head and Neck and Endocrine Oncology, Moffitt Cancer Center, Tampa, Florida.
Department of Otolaryngology-Head and Neck Surgery, University of South Florida, Tampa, Florida.
J Natl Compr Canc Netw. 2023 May;21(5):496-502.e6. doi: 10.6004/jnccn.2023.7008.
Patients with cancer require timely access to care so that healthcare providers can prepare an optimal treatment plan with significant implications for quality of life and mortality. The COVID-19 pandemic spurred rapid adoption of telemedicine in oncology, but study of patient experience of care with telemedicine in this population has been limited. We assessed overall patient experience of care with telemedicine at an NCI-designated Comprehensive Cancer Center during the COVID-19 pandemic and examined changes in patient experience over time.
This was a retrospective study of outpatient oncology patients who received treatment at Moffitt Cancer Center. Press Ganey surveys were used to assess patient experience. Data from patients with appointments between April 1, 2020, and June 30, 2021, were analyzed. Patient experience was compared between telemedicine and in-person visits, and patient experience with telemedicine over time was described.
A total of 33,318 patients reported Press Ganey data for in-person visits, and 5,950 reported Press Ganey data for telemedicine visits. Relative to patients with in-person visits, more patients with telemedicine visits gave higher satisfaction ratings for access (62.5% vs 75.8%, respectively) and care provider concern (84.2% vs 90.7%, respectively) (P<.001). When adjusted for age, race/ethnicity, sex, insurance, and clinic type, telemedicine visits consistently outperformed in-person visits over time regarding access and care provider concern (P<.001). There were no significant changes over time in satisfaction with telemedicine visits regarding access, care provider concern, telemedicine technology, or overall assessment (P>.05).
In this study, a large oncology dataset showed that telemedicine resulted in better patient experience of care in terms of access and care provider concern compared with in-person visits. Patient experience of care with telemedicine visits did not change over time, suggesting that implementing telemedicine was effective.
癌症患者需要及时获得医疗服务，以便医疗保健提供者能够制定最佳治疗方案，这对生活质量和死亡率有重要影响。COVID-19 大流行促使肿瘤科迅速采用远程医疗，但在该人群中，关于远程医疗患者护理体验的研究有限。我们评估了在 COVID-19 大流行期间，NCI 指定的综合癌症中心的远程医疗患者整体护理体验，并研究了患者体验随时间的变化。
这是一项回顾性研究，纳入在 Moffitt 癌症中心接受治疗的门诊肿瘤患者。使用 Press Ganey 调查评估患者体验。分析了 2020 年 4 月 1 日至 2021 年 6 月 30 日期间预约的患者数据。比较了远程医疗和面对面就诊的患者体验，并描述了远程医疗患者体验随时间的变化。
共有 33318 名患者报告了面对面就诊的 Press Ganey 数据，5950 名患者报告了远程医疗就诊的 Press Ganey 数据。与面对面就诊的患者相比，更多远程医疗就诊的患者对就诊的便利性（分别为 62.5%和 75.8%）和医疗服务提供者的关注（分别为 84.2%和 90.7%）给出了更高的满意度评分（均 P<.001）。调整年龄、种族/民族、性别、保险和诊所类型后，远程医疗就诊在便利性和医疗服务提供者的关注方面始终优于面对面就诊（均 P<.001）。在便利性、医疗服务提供者的关注、远程医疗技术和整体评估方面，远程医疗就诊的满意度随时间变化无显著差异（均 P>.05）。
在这项研究中，一个大型肿瘤学数据集表明，与面对面就诊相比，远程医疗在就诊便利性和医疗服务提供者的关注方面为患者提供了更好的护理体验。远程医疗就诊的患者护理体验随时间无变化，表明实施远程医疗是有效的。
